Skip to main content
SpringerLink
Log in

Refraktäre Hodentumore und Rezidive: Therapie

  • Living reference work entry
  • First Online:
Uroonkologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 167 Accesses

Zusammenfassung

Die Mehrzahl der Männer mit metastasiertem Hodenkrebs wird durch eine primäre Chemotherapie geheilt. Selten spricht jedoch die Erkrankung auf die primäre Behandlung ungenügend an oder tritt nach zunächst erfolgreicher Behandlung zu einem späteren Zeitpunkt erneut auf. Die dann erforderliche Salvage-Therapie kann bei vielen Betroffenen immer noch zu einer dauerhaften Heilung der Erkrankung führen. Allerdings ist die Salvage-Therapie komplizierter und nebenwirkungsreicher als die primäre Behandlung und sollte ausschließlich an Einrichtungen durchgeführt werden, die sich auf die Therapie dieser Patienten spezialisiert haben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Albers P, Dommer K, Muller SC (1998) Hodentumoren. Todesfälle und Rezidive nach inadäquater Therapie. Urologe A 37:625–628

    Article  CAS  Google Scholar 

  • Albers P, Ganz A, Hannig E et al (2000) Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 164:381–384

    Article  CAS  Google Scholar 

  • André F, Fizazi K, Culine S, Droz JP, Taupin P, Lhommé C, Terrier-Lacombe MJ, Théodore C (2000) The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer 36:1389–1394

    Article  Google Scholar 

  • Beck SDW, Foster RS, Bihrle R, Einhorn LH, Donohue JP (2005) Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 23:6149–6156

    Article  Google Scholar 

  • Beyer J, Albers P, Altena R (2013) Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 24:878–888

    Article  CAS  Google Scholar 

  • Donadio AC, Motzer RJ, Bajorin DF, Kantoff PW, Sheinfeld J, Houldsworth J, Chaganti RSK, Bosl GJ (2003) Chemotherapy for teratoma with malignant transformation. J Clin Oncol 21:4285–4291

    Article  CAS  Google Scholar 

  • Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R (2007) High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 357:340–348

    Article  CAS  Google Scholar 

  • Fankhauser CD, Honecker F, Beyer J, Bode PK (2015) Emerging therapeutic targets for male germ cell tumors. Curr Oncol Rep 17:54

    Article  Google Scholar 

  • Farhat F, Culine S, Theodore C, Bekradda M, Terrier-Lacombe MJ, Droz JP (1996) Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients. Cancer 77:1193–1197

    Article  CAS  Google Scholar 

  • Feldman D, Lorch A, Kramar A (2016) Brain metastases in patients with germ cell tumors: prognostic factors and treatment options – An analysis from the global germ cell cancer group. J Clin Oncol 34:345–351

    Article  Google Scholar 

  • George DW, Foster RS, Hromas RA, Robertson KA, Vance GH, Ulbright TM, Gobbett TA, Heiber DJ, Heerema NA, Ramsey HC, Thurston VC, Jung S-H, Shen J, Finch DE, Kelley MR, Einhorn LH (2003) Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol 21:113–122

    Article  Google Scholar 

  • Hartmann J, Schmoll HJ, Kuczyk MA, Candelaria M, Bokemeyer C (1997) Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors. Ann Oncol 8:531–538

    Article  CAS  Google Scholar 

  • Heidenreich A, Krege S, Flaßhove M (2004) Interdisziplinäre Kooperation in der Therapie von komplexen Patienten mit fortgeschrittenem testikulärem Keimzelltumor. Urol A 43:1521–1530

    Article  CAS  Google Scholar 

  • Heidenreich A, Ohlmann CH, Hegele A, Beyer J (2005) Repeat retroperitoneal lymphadenectomy in advanced testicular cancer. Eur Urol 47:64–71

    Article  Google Scholar 

  • Hendry WF, Norman AR, Dearnaley DP, Fisher C, Nicholls J, Huddart RA, Horwich A (2002) Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer 94:1668–1676

    Article  Google Scholar 

  • Horwich A, Shipley J, Huddart R (2006) Testicular germ-cell cancer. Lancet 367:754–765

    Article  CAS  Google Scholar 

  • International Prognostic Factor Study Group (2010) Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 28(33):4906–4911

    Article  Google Scholar 

  • Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marionv S, Sheinfeld J, Bosl GJ, Motzer RJ (2005) Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23:6549–6555

    Article  CAS  Google Scholar 

  • Kuczyk MA, Bokemeyer C, Kollmannsberger C, Corvin C, Anastasias S, Machtens S, Merseburger A, Wegener G, Stenzel A, Hartmann JT, Jonas U (2004) Late relapse after treatment for nonseminomatous germ cell tumors according to a single center-based experience. World J Urol 22:55–59

    Article  CAS  Google Scholar 

  • Loehrer PJ, Gonin R, Nichols CR, Weathers T, Einhorn LH (1998) Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16:2500–2504

    Article  CAS  Google Scholar 

  • Lorch A, Kollmannsberger C, Hartmann JT, Metzner B, Schmidt-Wolf IGH, Berdel BE, Weissinger F, Schleicher J, Egerer G, Haas A, Schirren R, Beyer J, Bokemeyer C, Rick O (2007) Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group. J Clin Oncol 25:2778–2784

    Article  CAS  Google Scholar 

  • Lorch A, Neubauer A, Hackenthal M et al (2009) High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors. Ann Oncol 21:820–825

    Article  Google Scholar 

  • Lorch A, Bascoul-Mollevi C, Kramar A et al (2011) Conventional-Dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database. J Clin Oncol 29(16):2178–2184

    Article  Google Scholar 

  • Lutke Holzik MF, Hoekstra HJ, Mulder NH, Suurmeijer AJH, Sleijfer DT, Gietema JA (2003) Non–germ cell malignancy in residual or recurrent mass after chemotherapy for nonseminomatous testicular germ cell tumor. Ann Surg Oncol 10:131–135

    Article  Google Scholar 

  • Miller KD, Loehrer PJ, Gonin R, Einhorn LH (1997) Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J Clin Oncol 15:1427–1431

    Article  CAS  Google Scholar 

  • Motzer RJ, Mazumdar M, Sheinfeld J, Bajorin DF, Macapinlac HA, Bains M, Reich L, Flombaum C, Mariani T, Tong WP, Bosl GJ (2000) Sequential dose-intensive paclitaxel, ifosfamide, carboplatin and etoposide salvage therapy for germ cell tumor patients. J Clin Oncol 18:1173–1180

    Article  CAS  Google Scholar 

  • Murphy BR, Breeden ES, Donohue JP, Messemer J, Walsh W, Roth BJ, Einhorn LH (1993) Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 11:324–329

    Article  CAS  Google Scholar 

  • Pico JL, Rosti G, Kramar A, Wandt H, Koza V, Salvioni R, Theodore C, Lelli G, Siegert W, Horwich A, Marangolo M, Linkesch W, Pizzocaro G, Schmoll HJ, Bouzy J, Droz JP, Biron P (2005) A randomized trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors. Ann Oncol 16:1152–1159

    Article  Google Scholar 

  • Porcu P, Bhatia S, Sharma M, Einhorn LH (2000) Results of treatment after relapse from high-dose chemotherapy in germ cell tumors. J Clin Oncol 18:1181–1186

    Article  CAS  Google Scholar 

  • Rick O, Bokemeyer C, Weinknecht S, Schirren J, Pottek T, Hartmann JT, Braun T, Rachud B, Weißbach L, Hartmann M, Siegert W, Beyer J (2004) Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. J Clin Oncol 22:3713–3719

    Article  CAS  Google Scholar 

  • Saxman SB, Nichols CR, Einhorn LH (1994) Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience. J Clin Oncol 12:1390–1393

    Article  CAS  Google Scholar 

  • Shahidi M, Norman A, Nicholls J, Dearnaley D, Horwich A, Huddart R (2002) Late recurrence in 1263 men with testicular germ cell tumours: multivariate analysis of risk factors and implications for management. Cancer 95:520–530

    Article  Google Scholar 

  • Sharp DS, Carver BS, Eggener SE, Kondagunta GV, Motzer RJ, Bosl GJ, Sheinfeld J (2008) Clinical outcome and predictors of survival in late relapse of germ cell tumor. J Clin Oncol 26:5524–5529

    Article  Google Scholar 

  • Sonneveld DJ, Sleijfer DT, Koops HS, Keemers-Gels ME, Molenaar WM, Hoekstra HJ (1998) Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer 82:1343–1351

    Article  CAS  Google Scholar 

  • Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fosså SD, Horwich A, Jones WG, Newlands ES, Oliver RT, Stenwig AE, Wilkinson PM (1998) Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party. Cancer 83:1409–1419

    Article  CAS  Google Scholar 

  • Vaena DA, Abonour R, Einhorn LH (2003) Long-term survival after high-dose salvage-chemotherapy for germ cell malignancies with adverse prognostic variables. J Clin Oncol 21:4100–4104

    Article  CAS  Google Scholar 

  • Vuky J, Tickoo SK, Sheinfeld J, Bacik J, Amsterdam A, Mazumdar M, Reuter V, Bajorin DF, Bosl GJ, Motzer RJ (2002) Salvage chemotherapy for patients with advanced pure seminoma. J Clin Oncol 20:297–301

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Inselspital, Medizinische Onkologie, Universitätsspital der Universität Bern, Bern, Schweiz

    Joerg Beyer

  2. Department of Urology, Urologic Oncology, Robot-assisted and Specialized Urologic Surgery, University Hospital Cologne, Köln, Deutschland

    Axel Heidenreich

  3. Westdeutsches Tumorzentrum, Innere Klinik (Tumorforschung), Universitätsklinikum Essen, Essen, Deutschland

    Martin Schuler

  4. Klinik Dr. Hancken GmbH, Stade, Deutschland

    Johannes Meiler

Authors
  1. Joerg Beyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Axel Heidenreich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Schuler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Johannes Meiler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joerg Beyer .

Editor information

Editors and Affiliations

  1. Helios Marien Klinikum Duisburg, Duisburg, Nordrhein-Westfalen, Germany

    Herbert Rübben

  2. Urologische Klinik/Poliklinik, Universitätsklinikum Rostock, Rostock, Mecklenburg-Vorpommern, Germany

    Oliver Hakenberg

  3. Klinik und Poliklinik für Urologie , Universitätsklinikum Jena, Jena, Thüringen, Germany

    Marc-Oliver Grimm

  4. Caritaskrankenhaus St. Josef, Regensburg, Germany

    Maximilian Burger

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Beyer, J., Heidenreich, A., Schuler, M., Meiler, J. (2019). Refraktäre Hodentumore und Rezidive: Therapie. In: Rübben, H., Hakenberg, O., Grimm, MO., Burger, M. (eds) Uroonkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54652-9_70-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54652-9_70-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54652-9

  • Online ISBN: 978-3-662-54652-9

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation